Animal Migraine Models for Drug Development: Status and Future Perspectives

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Animal Migraine Models for Drug Development : Status and Future Perspectives. / Jansen-Olesen, Inger; Tfelt-Hansen, Peer; Olesen, Jes.

I: C N S Drugs, Bind 27, Nr. 12, 2013, s. 1049-1068.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Jansen-Olesen, I, Tfelt-Hansen, P & Olesen, J 2013, 'Animal Migraine Models for Drug Development: Status and Future Perspectives', C N S Drugs, bind 27, nr. 12, s. 1049-1068. https://doi.org/10.1007/s40263-013-0121-7

APA

Jansen-Olesen, I., Tfelt-Hansen, P., & Olesen, J. (2013). Animal Migraine Models for Drug Development: Status and Future Perspectives. C N S Drugs, 27(12), 1049-1068. https://doi.org/10.1007/s40263-013-0121-7

Vancouver

Jansen-Olesen I, Tfelt-Hansen P, Olesen J. Animal Migraine Models for Drug Development: Status and Future Perspectives. C N S Drugs. 2013;27(12):1049-1068. https://doi.org/10.1007/s40263-013-0121-7

Author

Jansen-Olesen, Inger ; Tfelt-Hansen, Peer ; Olesen, Jes. / Animal Migraine Models for Drug Development : Status and Future Perspectives. I: C N S Drugs. 2013 ; Bind 27, Nr. 12. s. 1049-1068.

Bibtex

@article{f3ecba058d1041bd9d9784eb00709b62,
title = "Animal Migraine Models for Drug Development: Status and Future Perspectives",
author = "Inger Jansen-Olesen and Peer Tfelt-Hansen and Jes Olesen",
year = "2013",
doi = "10.1007/s40263-013-0121-7",
language = "English",
volume = "27",
pages = "1049--1068",
journal = "CNS Drugs",
issn = "1172-7047",
publisher = "Adis International Ltd",
number = "12",

}

RIS

TY - JOUR

T1 - Animal Migraine Models for Drug Development

T2 - Status and Future Perspectives

AU - Jansen-Olesen, Inger

AU - Tfelt-Hansen, Peer

AU - Olesen, Jes

PY - 2013

Y1 - 2013

U2 - 10.1007/s40263-013-0121-7

DO - 10.1007/s40263-013-0121-7

M3 - Journal article

C2 - 24234657

VL - 27

SP - 1049

EP - 1068

JO - CNS Drugs

JF - CNS Drugs

SN - 1172-7047

IS - 12

ER -

ID: 118441882